N@N

Marie Thibault Maintained (ABT) at Strong Buy with Increased Target to $143 on, Oct 20th, 2021

Marie Thibault of BTIG, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $136 to $143 on, Oct 20th, 2021.

Marie has made no other calls on ABT in the last 4 months.

There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 2 agree with Marie's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Simon Baker of "Redburn Partners" Initiated at Hold on, Thursday, October 14th, 2021
• Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $128 on, Tuesday, July 20th, 2021

These are the ratings of the 9 analyists that currently disagree with Marie

---

• Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $135 on, Sunday, October 10th, 2021
• Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $140 on, Friday, October 8th, 2021
• Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $140 on, Friday, October 1st, 2021
• Bob Hopkins of "B of A Securities" Maintained at Strong Buy and Held Target at $133 on, Tuesday, August 31st, 2021
• Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $130 on, Sunday, August 1st, 2021
• Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Friday, July 23rd, 2021
• Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $136 on, Friday, July 23rd, 2021
• Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $128 on, Friday, July 23rd, 2021
• Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021

Contributing Sources

---